Mereo BioPharma Group
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor w...
Social media
Mereo BioPharma Group Logo
About Mereo BioPharma Group
Mereo BioPharma Group plc (Mereo) operates as a clinical stage biopharmaceutical company. The Company develops medicines for rare and specialty diseases. Mereo serves the healthcare sector globally.
Address
One Cavendish Place, 4th Floor
London, W1G 0QF
United Kingdom
Year founded
2015
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
